NF-κB-inducing kinase is dispensable for activation of NF-κB in inflammatory settings but essential for lymphotoxin β receptor activation of NF-κB in primary human fibroblasts

Journal of Immunology

Volumn 167, Issue 10, 2001, Pages 5895-5903

  Smith, C ^a   Andreakos, E ^a   Crawley, J B ^a   Brennan, F M ^a   Feldmann, M ^a   Foxwell, B M J ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN INDUCING KINASE; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; LIPOPOLYSACCHARIDE; LYMPHOTOXIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; LTBR PROTEIN, HUMAN; LTBR PROTEIN, MOUSE; LYMPHOTOXIN BETA RECEPTOR; NF KAPPA B KINASE; NF-KAPPA B KINASE; PROTEIN SERINE THREONINE KINASE; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; MISSENSE MUTATION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; ADENOVIRUS; BIOSYNTHESIS; CELL CULTURE; CELL LINE; ENZYMOLOGY; FIBROBLAST; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HELA CELL; IMMUNOLOGY; MACROPHAGE; METABOLISM; MUTATION; PHYSIOLOGY;

ADENOVIRIDAE; ARTHRITIS, RHEUMATOID; CELL LINE; CELLS, CULTURED; CYTOKINES; FIBROBLASTS; GENETIC VECTORS; HELA CELLS; HUMANS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; LYMPHOTOXIN BETA RECEPTOR; MACROPHAGES; MUTATION; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035889229     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.10.5895     Document Type: Article

References (68)

1. Series introduction: The transcription factor NF-κB and human disease
2. NF-κB and the innate immune response
3. NF-κB: A key role in inflammatory diseases
4. Phosphorylation meets ubiquitination: The control of NF-κB activity
5. Apoptosis: Activate NF-κB or die?
6. Dysregulation of monocytic nuclear factor-κB by oxidized low-density lipoprotein
7. NF-κB: Ten years after
8. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
9. Role of NFκB in the mortality of sepsis
10. Efficient adenoviral infection with IκBα reveals that macrophage tumor necrosis factor α production in rheumatoid arthritis is NF-κB dependent
11. Defining therapeutic targets by using adenovirus: Blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares antiinflammatory mediators
12. The IκB proteins: Multifunctional regulators of Rel/NF-κB transcription factors
13. Rel/NF-κB/lκB family: Intimate tales of association and dissociation
14. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway
15. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation
16. Appearance of apparently ubiquitin-conjugated IκB-α during its phosphorylation-induced degradation in intact cells
17. Signal-induced degradation of IκBα requires site-specific ubiquitination
18. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation
19. Identification of the receptor component of the IκBα-ubiquitin ligase
20. IκBα ubiquitination is catalyzed by an SCF-like complex containing Skp1, cullin-1, and two F-box/WD40-repeat proteins, βTrCP1 and βTrCP2
21. Inducible degradation of IκBα by the proteasome requires interaction with the F-box protein h-βTrCP
22. The SCFβ-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro
23. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
24. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation
25. Identification and characterization of an IκB kinase
26. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK
27. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation
28. IKK-γ is an essential regulatory subunit of the IκB kinase complex
29. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation
30. Activation of IκB kinase β by protein kinase C isoforms
31. The interaction of p62 with RIP links the atypical PKCs to NF-κB activation
32. MEK kinase is involved in tumor necrosis factor α-induced NF-κB activation and degradation of IκB-α
33. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway
34. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases
35. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1
36. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2
37. NF-κB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-κB-inducing kinase and IκB kinase
38. Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1
39. NF-κB-inducing kinase is a common mediator of IL-17-, TNF-α-, and IL-1 β-induced chemokine promoter activation in intestinal epithelial cells
40. Differential IκB kinase activation and IκBα degradation by interleukin-1β and tumor necrosis factor-α in human U937 monocytic cells: Evidence for additional regulatory steps in κB-dependent transcription
41. Severe liver degeneration in mice lacking the IκB kinase 2 gene
42. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice
43. Female mice heterozygous for IKKγ/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti
44. NEMO/IKKγ-deficient mice model incontinentia pigmenti
45. Genomic rearangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti: The International Incontinentia Pigmenti (IP) Consortium
46. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase
47. IKKα controls formation of the epidermis independently of NF-κB
48. Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-κB-inducing kinase
49. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice
50. Defects of somatic hypermutation and class switching in alymphoplasia (aly) mutant mice
51. The splenic marginal zone is absent in alymphoplastic aly mutant mice
52. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
53. The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues
54. Nuclear retention of IκBα protects it from signal-induced degradation and inhibits nuclear factor κB transcriptional activation
55. A simplified system for generating recombinant adenoviruses
56. Methods for construction of adenovirus vectors
57. Selective regulation of cytokine induction by adenoviral gene transfer of IκBα into human macrophages: Lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-κB independent
58. Effective adenoviral transfer of IκBα into human fibroblasts and chondrosarcoma cells reveals that the induction of matrix metalloproteinases and proinflammatory cytokines is nuclear factor-κB dependent
59. Alveolar macrophages and T cells from sarcoid, but not normal lung are permissive to adenovirus infection and allow analysis of NF-κB dependent signalling pathways
60. Essential role of nuclear factor (NF)-κB-inducing kinase and inhibitor of κB (IκB) kinase α in NF-κB activation through lymphotoxin β receptor, but not through tumor necrosis factor receptor I
61. Effects of the NIK aly mutation on NF-κB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin β receptor, and CD40
62. Defective lymphotoxin-β receptor-induced NF-κB transcriptional activity in NIK-deficient mice
63. Critical role for the lymphotoxin pathway in the induction and progression of collagen-arthritis
64. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
65. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
66. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKγ) upon receptor stimulation
67. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-κB through IκB kinase-α and IκB kinase-β
68. 2-terminal kinase regulation but does not cause a measurable defect in NF-κB activation